Datalyze Corp (TSE:NDAT) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

Palvella Therapeutics completed a reverse merger with Pieris Pharmaceutical of Boston to become a public traded company, with ...

A pharmaceutical company founded by Houston medical leaders is set to go public via a merger, and it’s staying in town.

But the mega-merger may well damage the image of the industry further – capping off a year beset with controversies over price (Turing Pharma) and allegations of market manipulation (Valeant).

NewGenIvf Group (NIVF) announced that both parties involved in the previously announced reverse merger with European Wellness Investment ...

Inmagene Biopharmaceuticals, a biotech developing immunology treatments, will take over the Nasdaq listing of Ikena Oncology ...

Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million payment, ...

If the reverse merger is completed, the combined company will satisfy the market capitalization requirements to maintain its listing. NewGen scheduled a hearing with Nasdaq to appeal the delisting ...

Additionally, investors bid the stock higher amid confidence that Rocket Lab is poised for continued revenue growth. At the ...

DeepRock Minerals, Inc. (TSE:DEEP) has released an update. DeepRock Minerals Inc. has filed additional financial documents related to its spin-off ...